iCardiac Technologies

ERT acquires iCardiac Technologies

Monday, December 4, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory solutions that accelerate clinical research. Financial terms of the transaction were not disclosed.

[Read More]

iCardiac launches eCOA platform QPoint

Wednesday, February 22, 2017

iCardiac Technologies has launched QPoint, its next-generation eCOA platform, to address the growing demand for more efficient and innovative eCOA study services in drug development. In addition to a number of other benefits, QPoint delivers short and streamlined study configuration and startup to the industry.

[Read More]

iCardiac launches spirometry training standardization tool

Thursday, February 2, 2017

iCardiac Technologies, a centralized core laboratory specializing in respiratory and cardiac safety studies, has launched a Direct-to-Subject Pre-Coaching video tool to help minimize the variability in respiratory test data caused by differences in subject technique and technician coaching. The training videos will be embedded in equipment iCardiac sends to all trial sites and are brief enough to be shown to subjects at the beginning of each testing visit.

[Read More]

iCardiac acquires nSpire Health’s clinical trials division

Thursday, August 6, 2015

iCardiac Technologies, a Rochester, N.Y.-based global provider of cardiac safety assessment services to the pharmaceutical industry, has added respiratory and ePRO services to its suite of offerings through the acquisition of the clinical trials division of nSpire Health. iCardiac also has opened a new office in Longmont, Colo., to accommodate the project management, data management, customer support, IT, technology development and business development teams joining iCardiac from nSpire Health.

[Read More]